Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

A HER-2 protein vaccine shows promise in breast cancer immunotherapy

March 29, 2004

HuMax-CD4 receives fast track designation for cutaneous T-cell lymphoma

March 25, 2004

MLN-2704 selected for CMA Pilot 2 Program

March 19, 2004

Phase I pilot trial of L612 HuMAb in metastatic melanoma

March 18, 2004

Additional phase II data from Theratope study

March 17, 2004

Phase II study for MT-201 in breast cancer

March 11, 2004

Therapeutic antibodies with reduced side effects presented by Isis Innovation

March 9, 2004

European orphan drug status for Revlimid in MDS

March 5, 2004

Long-term survival data for Rencarex in metastatic renal cell carcinoma

March 5, 2004

New round of financing at Igeneon to advance lead candidates

March 4, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...